Factors affecting peripheral neuropathy induced by nanoparticle albumin‐bound paclitaxel in patients with pancreatic cancer
The higher the cumulative dose of Nab-P, treatment cycles and age, the more frequently and severely do the patients experience CIPN. In predicting the severity of CIPN using C<sub>max</sub>, minimally invasive VAMS is a feasible alternative to venous blood sampling.
Authors
- Jangik I. Lee (ORCID: https://orcid.org/0000-0002-5565-8323)
- Ji Kon Ryu (ORCID: https://orcid.org/0000-0001-8798-0491)
- Minseo Kang (ORCID: https://orcid.org/0009-0006-6818-5226)
- Seunghyun Yoo (ORCID: https://orcid.org/0000-0002-9273-1761)
- Myeong Hwan Lee (ORCID: https://orcid.org/0000-0002-9583-730X)
- Yeolmae Jung
- Hayun Lim
Institutions
- Seoul National University (KR)
- Seoul National University Hospital (KR)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1111/bcp.16210
- Citations
- 6
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea